Notably, transcriptional levels of c-Myc and EpCAM promoters in hepatic cancer cells were downregulated by the decreased level of SLC1A4, which was reversed by the transfection of the Flag-AKT plasmid. This evidence concerns the gene EPCAM and liver cancer.